Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenstrom macroglobulinemia Journal Article


Authors: Castillo, J. J.; Libby, E. N.; Ansell, S. M.; Palomba, M. L.; Meid, K.; Flynn, C. A.; Leventoff, C.; Hergott, C. B.; Sewastianik, T.; Morgan, E. A.; Carrasco, R.; Fromm, J. R.; Yang, G.; Hunter, Z.; Treon, S. P.
Article Title: Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenstrom macroglobulinemia
Keywords: bortezomib; dexamethasone; therapy; expression; consensus panel recommendations; 2nd international workshop; cd38
Journal Title: Blood Advances
Volume: 4
Issue: 20
ISSN: 2473-9529
Publisher: American Society of Hematology  
Date Published: 2020-10-27
Start Page: 5089
End Page: 5092
Language: English
ACCESSION: WOS:000582796200012
DOI: 10.1182/bloodadvances.2020003087
PROVIDER: wos
PMCID: PMC7594378
PUBMED: 33085756
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba